|
Q2 2026
|
99 |
5,708,925
|
BTSG, HSIC, BBIO, BV
|
13F-HR
|
8/14/2026 |
000139977026000008 |
|
Q1 2026
|
92 |
5,346,373
|
BTSG, HSIC, BBIO, CRGY
|
13F-HR
|
5/15/2026 |
000139977026000007 |
|
Q4 2025
|
91 |
6,254,847
|
BTSG, HSIC, BBIO, NIQ
|
13F-HR
|
2/17/2026 |
000139977026000005 |
|
Q3 2025
|
85 |
5,967,416
|
BTSG, HSIC, BBIO, NIQ
|
13F-HR
|
11/14/2025 |
000146393125000021 |
|
Q2 2025
|
76 |
4,840,715
|
BTSG, HSIC, BBIO, BV
|
13F-HR
|
8/14/2025 |
000146393125000009 |
|
Q1 2025
|
75 |
4,427,070
|
BTSG, HSIC, BBIO, BV
|
13F-HR
|
5/15/2025 |
000146393125000006 |
|
Q4 2024
|
68 |
3,734,469
|
BTSG, BBIO, BV, JETBLUE AIRWAYS CORP
|
13F-HR
|
2/14/2025 |
000146393125000003 |
|
Q3 2024
|
72 |
7,468,046
|
ONESTREAM INC, BTSG, BBIO, BV
|
13F-HR
|
11/14/2024 |
000146393124000018 |
|
Q2 2024
|
69 |
3,333,612
|
BTSG, BBIO, BV, JETBLUE AIRWAYS CORP
|
13F-HR
|
8/14/2024 |
000146393124000012 |
|
Q1 2024
|
67 |
3,877,190
|
BBIO, BRIGHTSPRING HEALTH SVCS INC, BV, JETBLUE AIRWAYS CORP
|
13F-HR
|
5/15/2024 |
000146393124000009 |
|
Q4 2023
|
71 |
3,383,954
|
BBIO, BV, FSK, APP
|
13F-HR
|
2/14/2024 |
000146393124000006 |
|
Q3 2023
|
73 |
2,849,241
|
BBIO, BV, FSK, APP
|
RESTATEMENT
|
1/22/2024 |
000146393124000003 |
|
Q2 2023
|
71 |
3,229,395
|
APP, BBIO, FSK, BV
|
13F-HR
|
8/14/2023 |
000172554723000244 |
|
Q1 2023
|
82 |
3,322,439
|
APP, BBIO, FSK, BV
|
13F-HR
|
5/15/2023 |
000146393123000007 |
|
Q4 2022
|
126 |
2,963,177
|
APP, BV, FSK, BBIO
|
13F-HR
|
2/14/2023 |
000146393123000004 |
|
Q3 2022
|
216 |
4,979,092
|
APP, FISV, BV, LAUR
|
13F-HR
|
11/14/2022 |
000146393122000011 |
|
Q2 2022
|
264 |
7,521,335
|
FISV, APP, BV, FSK
|
13F-HR
|
8/12/2022 |
000146393122000008 |
|
Q1 2022
|
276 |
11,028,774
|
APP, FISV, BV, FSK
|
13F-HR
|
5/16/2022 |
000156761922011020 |
|
Q4 2021
|
208 |
18,227,569
|
APP, FISV, EDR, BV
|
13F-HR
|
2/14/2022 |
000156761922004143 |
|
Q3 2021
|
185 |
20,050,165
|
APP, FISV, BBIO, BV
|
13F-HR
|
11/15/2021 |
000156761921020504 |
|
Q2 2021
|
141 |
24,656,728
|
APP, FISV, BBIO, IR
|
13F-HR
|
8/16/2021 |
000156761921015746 |
|
Q1 2021
|
101 |
19,849,035
|
FISV, IR, BBIO, ASO
|
13F-HR
|
5/17/2021 |
000156761921010548 |
|
Q4 2020
|
60 |
19,711,494
|
FISV, BBIO, IR, ASO
|
13F-HR
|
2/16/2021 |
000156761921004092 |
|
Q3 2020
|
65 |
17,509,665
|
FISV, IR, BBIO, BV
|
13F-HR
|
11/16/2020 |
000156761920019910 |
|
Q2 2020
|
67 |
16,386,208
|
FISV, IR, BBIO, BV
|
13F-HR
|
8/14/2020 |
000156761920015535 |
|
Q1 2020
|
50 |
15,675,657
|
FISV, IR, BBIO, BV
|
13F-HR
|
5/15/2020 |
000156761920010611 |
|
Q4 2019
|
54 |
20,455,805
|
FISV, GDI, BBIO, BV
|
13F-HR
|
2/14/2020 |
000156761920003955 |
|
Q3 2019
|
52 |
17,777,800
|
FISV, GDI, BV, BBIO
|
13F-HR
|
11/14/2019 |
000156761919021529 |
|
Q2 2019
|
55 |
8,117,692
|
GDI, BV, BBIO, PRAH
|
13F-HR
|
8/14/2019 |
000156761919016938 |
|
Q1 2019
|
55 |
6,572,745
|
GDI, BV, PRAH, KREF
|
13F-HR
|
5/15/2019 |
000156761919011160 |
|
Q4 2018
|
56 |
5,483,174
|
GDI, PRAH, BV, KREF
|
13F-HR
|
2/13/2019 |
000156761919003744 |
|
Q3 2018
|
59 |
8,805,734
|
GDI, BV, EYE, PRAH
|
13F-HR
|
11/14/2018 |
000156761918006241 |
|
Q2 2018
|
51 |
8,783,164
|
GDI, BV, PRAH, EYE
|
13F-HR
|
8/14/2018 |
000156761918000992 |
|
Q1 2018
|
42 |
8,223,848
|
GDI, PRAH, EYE, KREF
|
13F-HR
|
5/15/2018 |
000114036118023893 |
|
Q4 2017
|
52 |
10,112,034
|
GDI, EYE, PRAH, KREF
|
13F-HR
|
2/14/2018 |
000114036118008215 |
|
Q3 2017
|
1 |
73,501
|
WRD
|
NEW HOLDINGS
|
2/14/2018 |
000114036118008207 |
|
Q3 2017
|
52 |
8,574,329
|
GDI, PRAH, USFD, KREF
|
13F-HR
|
11/14/2017 |
000114036117042773 |
|
Q2 2017
|
1 |
68,259
|
WRD
|
NEW HOLDINGS
|
2/14/2018 |
000114036118008196 |
|
Q2 2017
|
2 |
510,857
|
KREF, VRS
|
NEW HOLDINGS
|
11/14/2017 |
000114036117042748 |
|
Q2 2017
|
45 |
8,248,509
|
GDI, PRAH, USFD, GDDY
|
13F-HR
|
8/14/2017 |
000114036117031949 |
|
Q1 2017
|
1 |
60
|
VRS
|
NEW HOLDINGS
|
11/14/2017 |
000114036117042731 |
|
Q1 2017
|
1 |
9,790
|
NOMD
|
NEW HOLDINGS
|
6/29/2017 |
000114036117026686 |
|
Q1 2017
|
49 |
5,553,005
|
USFD, PRAH, GDDY, EGL
|
13F-HR
|
5/15/2017 |
000110465917032805 |
|
Q4 2016
|
1 |
71
|
VRS
|
NEW HOLDINGS
|
11/14/2017 |
000114036117042723 |
|
Q4 2016
|
53 |
6,263,511
|
USFD, PRAH, GDDY, HCA
|
13F-HR
|
2/14/2017 |
000110465917009304 |
|
Q3 2016
|
1 |
65
|
VRS
|
NEW HOLDINGS
|
11/14/2017 |
000114036117042720 |
|
Q3 2016
|
56 |
8,027,000
|
USFD, WBA, PRAH, GDDY
|
13F-HR
|
11/14/2016 |
000110465916156936 |
|
Q2 2016
|
51 |
9,469,117
|
WBA, USFD, PRAH, GDDY
|
13F-HR
|
8/15/2016 |
000110465916139802 |
|
Q1 2016
|
53 |
10,060,887
|
WBA, PRAH, HCA, ZBH
|
13F-HR
|
5/16/2016 |
000110465916121432 |
|
Q4 2015
|
55 |
10,269,233
|
WBA, PRAH, HCA, ZBH
|
RESTATEMENT
|
4/1/2016 |
000110465916109348 |
|
Q3 2015
|
69 |
9,402,526
|
WBA, PRAH, HCA, ZBH
|
RESTATEMENT
|
4/1/2016 |
000110465916109340 |
|
Q2 2015
|
58 |
11,053,859
|
WBA, PRAH, HCA, SJM
|
RESTATEMENT
|
4/1/2016 |
000110465916109337 |
|
Q1 2015
|
90 |
9,614,168
|
WBA, PRAH, HCA, SJM
|
13F-HR
|
5/15/2015 |
000110465915038732 |
|
Q4 2014
|
82 |
7,625,871
|
WBA, HCA, PRAH, NLSN
|
13F-HR
|
2/17/2015 |
000110465915011324 |
|
Q3 2014
|
88 |
3,470,733
|
HCA, NLSN, WAG, GILEAD SCIENCES INC
|
13F-HR
|
11/14/2014 |
000110465914081036 |
|
Q2 2014
|
78 |
3,376,338
|
HCA, NLSN, WAG, RNET
|
13F-HR
|
8/14/2014 |
000110465914061103 |
|
Q1 2014
|
134 |
5,748,556
|
HCA, NLSN, MRVL, NXPI
|
RESTATEMENT
|
8/14/2014 |
000110465914061093 |
|
Q4 2013
|
126 |
5,825,975
|
HCA, NLSN, NXPI, MRVL
|
13F-HR
|
2/14/2014 |
000110465914010629 |